
AZD1222 Vaccine by AstraZeneca Shows Similar Immune Responses among Old and Young Adults
The joint vaccine being developed by the duo of Oxford University and AstraZeneca Plc has reportedly produced a similar immune response in older adults as much as it does for the younger ones.